| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 4.215 | 39.025 | 59.400 | 59.836 |
| Total Income - EUR | - | - | - | - | - | - | 4.258 | 44.043 | 59.812 | 74.227 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.801 | 10.552 | 32.846 | 57.615 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.457 | 33.491 | 26.966 | 16.612 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 2.416 | 33.150 | 26.580 | 16.103 |
| Employees | - | - | - | - | - | - | 1 | 1 | 2 | 3 |
Check the financial reports for the company - Ld Cont Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 710 | 201.989 | 197.227 |
| Current Assets | - | - | - | - | - | - | 3.390 | 35.644 | 5.572 | 123.220 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 468 | 9.220 |
| Receivables | - | - | - | - | - | - | 354 | 27.059 | 2.056 | 112.190 |
| Cash | - | - | - | - | - | - | 3.036 | 8.586 | 3.048 | 1.809 |
| Shareholders Funds | - | - | - | - | - | - | 2.456 | 35.614 | 62.086 | 77.842 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 933 | 740 | 145.476 | 152.093 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 92.000 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Ld Cont Laboratory S.r.l.